0000899243-15-003909.txt : 20150824 0000899243-15-003909.hdr.sgml : 20150824 20150824180614 ACCESSION NUMBER: 0000899243-15-003909 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150821 FILED AS OF DATE: 20150824 DATE AS OF CHANGE: 20150824 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 LEXINGTON AVENUE STREET 2: . CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-531-5965 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Holmes Scott A CENTRAL INDEX KEY: 0001537670 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 151071819 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-08-21 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001537670 Holmes Scott A C/O KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022 0 1 0 0 Chief Financial Officer Common Stock 2015-08-21 4 P 0 5000 5.718 A 54742 D The reporting person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 2,758 shares, with the reporting person's sale of 2,758 shares of common stock at a price of $7.87 per share on July 31, 2015. The reporting person has agreed to pay Keryx $5,935.22, representing the full amount of the profit realized in connection with the short-swing transaction. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices, ranging from $5.717 to $5.72, through a trade order executed by a broker-dealer. The price reported in Column 4 is a weighted average price. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. Includes 45,000 shares of restricted stock. /s/ Brian Adams 2015-08-24